Clinical Trials
94 trialsRisk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Fox Chase Cancer Center
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
University of Washington
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NRG Oncology
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Mayo Clinic
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
NICSA
Aarhus University Hospital
HIPEC-PMP
University of Southampton
ICARuS
Memorial Sloan Kettering Cancer Center
Adaptive Radiation in Anal Cancer
Columbia University
REDEL
University of Cincinnati
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
City of Hope Medical Center
FOXHIPECT4
Maimónides Biomedical Research Institute of Córdoba
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies
Washington University School of Medicine
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
University of Southern California
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
University of Chicago
COBRA-NMIBC
Aarhus University Hospital
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
CANAL-IMRT-01
Centre Francois Baclesse
KANALRAD
Federation Francophone de Cancerologie Digestive
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
CORINTH
Cardiff University
Chemoembolization for Lung Tumors
Memorial Sloan Kettering Cancer Center
GAIN INST
Hospital Centre Biel/Bienne
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
Tongji Hospital
SAFIR02_Breast
UNICANCER
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Bruckner Oncology
Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
University of Florida
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Proton Therapy in Reducing Toxicity in Anal Cancer
University of Cincinnati
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
Nottingham University Hospitals NHS Trust
POLO
University of Bern
CHECK
Mario Negri Institute for Pharmacological Research
HIPECT4
Maimónides Biomedical Research Institute of Córdoba
Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma
McMaster University
BCG+MM
University of Sydney
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
BIC
Corewell Health West
Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
M.D. Anderson Cancer Center
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Mayo Clinic
BL-PDT-RCT
First Affiliated Hospital Xi'an Jiaotong University
CRIMI
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
WUHIPEC02
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer
M.D. Anderson Cancer Center
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
UNICANCER
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center